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IntroductIon
During April 2009 a novel A(H1N1) influenza virus 
emerged in Mexico and since then has spread world-
wide. The virus was found to be an A(H1N1) virus 
that was antigenically and genetically unrelated to hu-
man seasonal influenza viruses and genetically related 
to viruses known to circulate in swine1.
Immediately, Greece enhanced the surveillance 
system. A telephone hotline was used to provide in-
formation and guidance to the public, advise health 
professionals, and guide cases under investigation for 
pandemic H1N1 2009 to designated reference hospi-
tals for clinical evaluation and nasopharyngeal swab 
collection. Specimens were sent to one of the two 
reference laboratories, in Athens (Hellenic Pasteur In-
stitute) covering southern Greece and in Thessaloniki 
(Aristotle University of Thessaloniki, Medical School, 
2nd Department of Microbiology) covering northern 
Greece. Instructions were posted on the walls of every 
public building, including universities and hospitals. 
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Guidelines for case and contact management and for 
infection control were prepared by the Hellenic Cen-
tre for Disease Control and Prevention (KEELPNO)2. 
These were sent to hospitals and published on the 
KEELPNO website (http://www.keelpno.gr/articles/
topic/?id=994). At the Aristotle University of Thes-
saloniki, a University Pandemic Committee was im-
mediately established and measures were taken to in-
form students how to react in case they experience a 
respiratory infection. Specifically, they were advised 
not to attend lectures and to report the infection to the 
Departmental and the School secretary. 
Two pandemic waves were eventually identified. 
The first wave which was shorter occurred during the 
summer months, weeks 27-35, following the initial 
introduction of the novel virus in Greece. During the 
second longer and more severe wave, weeks 43-52, 
most of the secondary schools were occluded, either 
as a precautionary measure or for quarantine purposes. 
A similar impact to the university function was indeed 
expected. From studies conducted in Greece, in other 
countries of Europe and America, but also in WHO, it 
was determined that children and young adults were 
the groups that were mostly affected by the H1N1 
2009 pandemic. 
The scope of this study was to identify the actual 
impact of the pandemic to the 17-25 year age group 
and to the normal University operation, using epide-
miological data obtained from the National Influenza 
Center for northern Greece, which is hosted at the 2nd 
Department of Microbiology, Medical School, Aris-
totle University of Thessaloniki, as well as from the 
separate University departments.
MeTHodS
The study was conducted in two parts:
a) Epidemiological data was obtained from this 
Center, regarding the 17-25 year age group. In total 
4949 suspected pharyngeal swabs were examined. All 
clinical specimens were accompanied by a Standard 
Form with information on age, sex, date of onset, date 
of specimen collection, place of residence, clinical 
features and complications of each patient, travel his-
tory, vaccination history and administration of antivi-
ral treatment. 
RNA was extracted from the clinical specimen 
using Qiagen Viral RNA mini kit, according to the 
manufacturer’s instructions and pandemic H1N1 
2009 infections were confirmed using the CDC swine 
influenza real-time RT-PCR kit, following WHO rec-
ommendations. A “confirmed case” was defined as a 
person tested positive for pandemic H1N1 2009 virus. 
Results were reported to KEELPNO, WHO (World 
Health Organization) and ECDC (European Centre 
for Disease Control)3.
b) Absence records from the 3rd year of study, first 
semesters of 2008-2009 and 2009-2010, were obtained 
from 6 departments of the School of Medicine, Aristo-
tle University of Thessaloniki, in order to observe the 
department’s function and compare it with the previ-
ous year. Information was also collected from the ap-
propriate departments and from the school secretary 
regarding student reports of absence, as well as reports 
of respiratory infections during the first semester, 15th 
of October 2009-15th of January 2010, a period which 
coincides with the second pandemic wave. 
A questionnaire was also given to 100 medicine 
students, studying at various semesters, between 17-25 
years of age, in order to gather information regarding 
their nationality, travel history and most importantly 
respiratory infection history at the period of interest, 
laboratory confirmation of infection, vaccination sta-
tus and antiviral drug treatment.
ReSUlTS
a) On 27th of May 2009, the first pandemic influenza 
H1N1 2009 virus was detected in northern Greece at 
a 20-year old student returning from the United King-
dom4. Between April 2009 and March 2010, 1632 
specimens were confirmed infections (33%). The first 
wave which was shorter occurred during the summer 
months, weeks 27-35, following the initial introduc-
tion of the novel virus in Greece. During the second 
longer and more severe wave, weeks 43-52, most of 
the secondary schools were occluded, either as a pre-
cautionary measure or for quarantine purposes.
The age distribution showed a trend towards chil-
dren and young adults, with 362 (22%) of the con-
firmed cases being at the 17-25 age group. During the 
first university semester period (15th October 2009- 
15th January 2010) 202 (54%) of the examined 17-
25 year old cases were found positive for the novel 
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virus. Sex distribution showed similar infection rates 
at both sexes (53% male and 47% female). (Table 1) 
(P < 0.05).
The analysis of these cases showed that after some 
sporadic cases and a slow increase in June 2009, a 
significant increase of newly reported cases was ob-
served at mid July. During this first wave, the majority 
of the infected individuals (70%) were travellers. 9% 
of the infected 17-25 individuals reported a travel his-
tory mostly during the summer period. A second peak 
initiated at week 43 and lasted until the end of 2009. 
(Table 2).
83% of confirmed cases were presented with mild 
ILI (Influnza-Like-Illness), with fever ranging from 
38- 40,5°C, acute onset of symptoms, cough, catarrh, 
sore throat, fatigue, headache, muscle pain and in 
some cases conjunctivitis, diarrhoea and/or vomiting.
Among the 17-25 age group cases, 17% were hos-
pitalized. The majority of them were during months 
November and December. The medical complica-
tions related to hospitalisation were acute respiratory 
failure, pneumonia, hypoxia, acute tracheitis, and 
tracheobronchitis. A wide age range distribution was 
observed in hospitalised patients, but more severe out-
comes were generally associated with older patients 
(median age 52 years old). At the age group of inter-
est, of the 362 confirmed cases, 19% developed more 
severe symptoms. Specifically, 35 patients developed 
pneumonia, 17 had difficulty in breathing, 8 developed 
ARDS, 2 cardiac disorder, 1 neurological disorders, 1 
polyorganic failure, 3 conjunctivitis.
In total, 45 (2.7%) confirmed cases of pandemic 
Table 1. Percentage of examined and confirmed 17-25 year old cases during the whole pandemic  





Confirmed 17-25 cases 
(% of the total confirmed)
Confirmed 17-25 cases 
(% of the total examined)
Apr. 2009 - Jan. 2010 4949 1632 (33%) 362 (22%) 362 (7,3%)
Oct. 2009 - Jan. 2010 2771 1216 (44%) 202 (17%) 202 (7,3%)
Table 2. Two pandemic influenza waves. Notified cases of influenza-like illnesses (ILI) and laboratory confirmed  
pandemic H1N1 2009 infections by week (19-53).
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H1N1 2009 infection were fatal. Most of them were 
between 50-81 years of age, while 2 (0.1%) belonged 
to the 17-25 year age group. Obesity has been consid-
ered as a possible risk factor of the fatal cases. How-
ever, there were also a small number of asymptomatic 
cases, mostly detected during the summer period. The 
number of asymptomatic cases was possibly higher, 
but this could not be determined, as at the progress of 
the pandemic only severe cases were laboratory ex-
amined.
Regarding the antiviral treatment, at the onset of 
the pandemic, all patients received oseltamivir (Tami-
flu) after the laboratory confirmation of pandemic 
H1N1 2009 infection, but only 21% of the cases were 
treated from the onset of the symptoms. After wide-
spread transmission within the country, patients no 
longer received treatment unless necessary. During 
the period September to December, only 75 confirmed 
cases received antiviral treatment (5,2%), 27 of them 
were at the 17-25 age group.
Regarding the vaccination status of the age group 
of study, 11 patients (3%) were vaccinated against 
seasonal influenza (2009-2010 season), the majority 
of the vaccinations occurred during November. It is 
worth mentioning that 5 of the confirmed pandemic 
H1N1 2009 cases have been vaccinated with the vac-
cine that contained the pandemic strain. 2% was vac-
cinated against S. pneumoniae.
b) Data that was obtained the files of the Medical 
School, Aristotle University of Thessaloniki for a total 
of 6 departmental units, showed that the number of 3rd 
year registered students was 373 at the 2008-2009 ac-
ademic year and 313 at the 2009-2010 academic year. 
The number of absentees were 815 and 852 respec-
tively, whereas students that replenished the 3rd year/ 
1st semester obligatory laboratories were 297 and 343 
respectively. No statistical significance was found 
(P < 0,05). Only 7 students notified the department 
secretary for absence because of influenza illness, 
whereas none informed the Univeristy Pandemic 
Committee or the School Secretary regarding their ill-
ness, as they were specifically advised. 
Results from the questionnaire showed that 71%, 
out of 100 individuals, reported that they indeed ex-
perienced an upper respiratory infection during the 
period of study. Regarding vaccination, 3% were vac-
cinated against pandemic influenza, 3% against com-
mon flu and 6% against S. pneumoniae. One student 
confirmed the influenza infection by PCR and none 
was admitted to a hospital or received Tamiflu treat-
ment. No relevance was found between travel history 
or nationality with the history of respiratory infec-
tions. 
dISCUSSIoN
The results provide an overview of the epidemiologi-
cal characteristics of 362 confirmed infections from 
pandemic influenza H1N1 2009, in northern Greece, 
between April 2009 to March 2010. 22% of infected 
individuals belonged to the 17-25 age group.
The age distribution of the infections clearly in-
dicates that the rate of infection is greater in the age 
group of 6-16 years old (40%), followed by the 17-25 
age group (22%). (Table 1) It is interesting that 54% 
of the examined 17-25 year old cases were positive 
for the novel virus during the first university semester 
period. (Table 1). The very low incidence of infec-
tions at individuals over 60 years of age is consistent 
with studies from other countries5,6. It is still unclear if 
the low incidence is due to partial immunity of older 
individuals from former infections with H1N1 influ-
enza viruses or because the virus was not sufficiently 
introduced in this subpopulation. Sex distribution, on 
the other hand, showed similar infection rates at both 
sexes, which seems to be similar to reports from other 
countries7.
Additionally, the analysis of these cases showed 
that the first significant increase of newly reported 
cases was observed at mid July, a trend which was 
also reported from other countries in Europe 8. Dur-
ing this first wave, the majority of infected individuals 
were travellers (70%). The age group under investiga-
tion, 17-25, represent the group that was mostly trav-
elling at during this period. A second pandemic wave 
initiated at week 44 and lasted until the end of 2009. 
Since the beginning of January, there is a downward 
trend in Greece. (Table 2).
The data show that most common symptoms in-
clude fever, cough, catarrh, sore throat, fatigue, 
headache and muscle pain, and most infections with 
pandemic influenza had mild, uncomplicated clini-
cal features. This agrees with reports from other 
countries9,10. 81% of 17-25 year old individuals de-
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veloped mild infection from influenza. Asymptomatic 
patients were mostly detected during the summer peri-
od, during which all contacts of laboratory confirmed 
cases were investigated. 
After widespread transmission of the virus within 
the country, clinicians had to laboratory-confirm the 
infection only in more severe cases. It is also remark-
able that the hospitalisation rate changed considerably 
over the weeks. During the first weeks, the majority of 
cases were hospitalised only due to infection control 
measures. As the pandemic progressed, hospitalisa-
tion was considered as a proxy for the severity of the 
disease in patients. The hospitalisation rate increased 
dramatically during November and December, as al-
most 90% of hospitalisations occurred this period. A 
closer look at those cases shows that patients with un-
derlying conditions had two times higher hospitalisa-
tion rate than in cases without underlying conditions, 
while more severe outcomes during hospitalisation 
were generally associated with older patients. This is 
similar to findings from other countries as well7. At 
the age group of interest, hospitalisation occurred at 
the 17% of cases. This percentage corresponds to the 
number of 17-25 year old cases that developed sever-
est symptoms (19%). It is also important to note that 
some hospitalisations were due to isolation purposes 
or due to underlying medical conditions and therefore 
the proportion to patients admitted to a hospital is not 
an indicator of the severity of the disease. 
According to our results the death rate was 2.7%, 
somewhat higher than the percentage worldwide (1,2-
1,3%), though the mortality in Europe had not been 
reported higher than 0,44% (http://www.who.int/csr/
disease/swineflu/en/). Regarding this relatively high 
case-fatality ratio, it should be considered that only 
the laboratory-confirmed cases were accounted and 
that during the second and more severe wave, only 
cases with severe symptoms were examined. In fact, 
only 2 confirmed cases in the 17-25 age group were 
fatal. Obesity has been generally considered as a pos-
sible risk factor of the fatal cases11. 
In the beginning of the pandemic in Greece, anti-
viral treatment was administered to all patients after 
laboratory confirmation of the infection. This policy 
was reported by other countries as well 12, and was 
soon abandoned due to the high risk of development 
of resistant pandemic H1N1 2009 strains. After wide-
spread transmission within the country, antiviral treat-
ment was limited to complicated or high-risk cases. 
17-25 year old confirmed cases rarely received antivi-
ral treatment (7%).
Additionally, according to the epidemiological 
analysis, 3% of the confirmed 17-25 year old cases 
were vaccinated for seasonal influenza (2009-2010 
season), while the majority of the vaccination oc-
curred during November. It is notable that 1% of the 
17-25 year old patients with confirmed pandemic 
H1N1 2009 infection had been vaccinated with the 
vaccine that contained the pandemic strain. However, 
the fact that they developed the symptoms only 2-3 
days after the vaccination indicates that they had not 
any vaccine coverage at the time of the infection.
Conclusively, it seems that the student age group 
(17-25 years) was of the most affected group from 
the H1N1 2009 pandemic. The second most severe 
pandemic wave coincided with the 1st University Se-
mester and it was expected that the pandemic would 
have a huge impact on the function of the university, 
as it did with secondary schools at this period. How-
ever, data that was gathered from the Medical School 
of the Aristotle University of Thessaloniki showed 
that the various departments were fully operational 
and functioned normally during the pandemic period. 
There was no significant difference at the absence lev-
els compared to the previous year and only 7 out of 
313 students reported an influenza infection, though 
they failed to report it to the School Secretary as they 
were specifically advised from the University Pan-
demic Committee. These facts raise a question as to 
whether the medical students did not get infected at 
all, or maybe a mild infection was not sufficient to 
keep them away from the classroom. Interestingly, ac-
counting the questionnaire answers, 71% did report 
an influenza like illness during the period of study. 
The high proportion of reported infections coincides 
with the fact that the student age group 17-25 years, 
was proven to be of the higher affected groups. It 
was evident however, that all students failed to re-
port their respiratory infection to the Medical School 
secretary, despite being specifically advised to do so. 
Only 1 student confirmed the respiratory infection at 
the laboratory. Medicine students also failed to vac-
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cinate, despite the fact that they are constantly located 
in hospitals and health care units. The conflict of the 
data could be attributed to the fact that their infections 
were mild. It is probable that they have also developed 
a cross-immunity level, due to their constant presence 
in hospitals.
Clearly, the young adults were mostly affected by 
the influenza pandemic. Constant epidemiological 
sur veillance is considered essential, to monitor the ef-
fect of the novel virus to this population. It would be 
useful if efforts were focused in persuading students 
to follow the instructions and report their possible in-
fections to the Pandemic Committee.
ΠΕΡΙΛΗΨΗ: Εισαγωγή: To 2009 ένας νέος Α(Η1Ν1) ιός γρίπης εμφανίσθηκε και προκάλεσε πανδημία. Ο σκοπός αυτής 
της μελέτης ήταν να προσδιοριστεί η επίπτωση της πανδημίας στην ηλικιακή ομάδα 17-25 ετών και στην ομαλή λειτουργία 
του πανεπιστημίου.
Μέθοδοι: α) Λήφθηκαν επιδημιολογικά δεδομένα από το Εθνικό Κέντρο Γρίπης της Βόρειας Ελλάδας. Συνολικά 4949 ύποπτα 
φαρυγγικά επιχρίσματα εξετάστηκαν στο Εθνικό Κέντρο Γρίπης για τη Βόρεια Ελλάδα. β) Λήφθηκαν τα αρχεία απουσιών 
του πρώτου εξαμήνου του 2008-2009 και 2009-2010 και δόθηκε ερωτηματολόγιο σε 100 φοιτητές της Ιατρικής Σχολής του 
Αριστοτελείου Πανεπιστημίου Θεσσαλονίκης.
Αποτελέσματα και Συζήτηση: Δύο πανδημικά κύματα προσδιορίστηκαν, το πρώτο τις εβδομάδες 27-35 και το δεύτερο τις 
εβδομάδες 43-52.
Από τα 4949 εξετασθέντα δείγματα, 1632 επιβεβαιώθηκαν πανδημικές Η1Ν1 2009 λοιμώξεις (33%), και 362 (22%) ανήκε 
στην ηλικιακή ομάδα 17-25. 53% ήταν άρρενες και 47% ήταν θήλυς. Οι περισσότερες λοιμώξεις αυτής της ομάδας ήταν 
ήπιες, και εμφάνισαν συμπτώματα γρίπης. 19% εμφάνισε πνευμονία ή άλλες επιπλοκές και 2 ήταν θανατηφόρες. Μόνο 4% 
εμβολιάσθηκε κατά της γρίπης και 2% κατά του S. pneumoniae. Μόνο 7% έλαβε θεραπεία με Tamiflu. 9% σημείωσε ιστορικό 
ταξιδιού σχετιζόμενο με τη μόλυνσή τους. 
β) Το δεύτερο κύμα συνέπεσε με το 1ο Ακαδημαϊκό εξάμηνο. Ωστόσο, καμία στατιστικά σημαντική διαφορά μεταξύ των 
απουσιών κατά το 2008-2009 και 2009-2010 εντοπίστηκε και κανένας φοιτητής δεν δήλωσε νόσο.
Συμπερασματικά, ενώ η ηλικιακή ομάδα 17-25 ήταν από τις περισσότερο προσβεβλημένες από τον νέο ιό, φαίνεται πως δεν 
υπήρξε καμία επίπτωση στη φυσιολογική λειτουργία του Πανεπιστημίου.
Λέξεις Κλειδιά: Πανδημία, Γρίπη, Φοιτητές, Πανεπιστήμιο, Ελλάδα.
Επιπτώσεις της πανδημίας γρίπης Α(Η1Ν1) 2009 στην ηλικιακή ομάδα 17-25  
και στους φοιτητές της Ιατρικής Σχολής του  
Αριστοτελείου Πανεπιστημίου Θεσσαλονίκης.
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